Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The change reflects an update to the ClinicalTrials.gov record history page/versioning and revision label rather than substantive changes to the study information itself.
    Difference
    0.5%
    Check dated 2026-04-24T06:10:59.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:45.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.0 replaces v3.4.3 in the Record History page.
    Difference
    0.1%
    Check dated 2026-03-19T05:31:03.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new revision (v3.4.3) was added to the Record History, and the previous revision (v3.4.2) was removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:09.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and an older maintenance notice (v3.4.1) was removed; the changes pertain to site version updates and operating status notices. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T14:18:20.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added a site-wide notice regarding government funding and the NIH Clinical Center status, and updated the release to Revision: v3.4.1 while removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:29:38.000Z thumbnail image

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.